ClassID:

20900

A61K38/08 - page 11 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Recent Application in this class:
#3001
20090004172
2009-01-01

SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION

#3002
20080318871
2008-12-25

Treatment of neurological disorders

#3003
20080318870
2008-12-25

SYNTHETIC BILE ACID COMPOSITIONS AND METHODS

#3004
20080312156
2008-12-18

In-Situ Crosslinkable Elastin-Like Polypeptides for Defect Filling in Cartilaginous Tissue Repair

#3005
20080306009
2008-12-11

Immunoregulatory compositions

#3006
20080306003
2008-12-11

Viral/bacterial toxin polypeptides and methods of using same

#3007
20080300190
2008-12-04

Peptides, derivatives and analogs thereof, and methods of using same

#3008
20080299108
2008-12-04

Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue

#3009
20080293628
2008-11-27

Methods and compositions for the inhibition of thrombus formation

#3010
20080279924
2008-11-13

HLA class I A2 tumor associated antigen peptides and vaccine compositions

#3011
20080274979
2008-11-06

Treatment of leaky or damaged tight junctions and enhancing extracellular matrix

#3012
20080274951
2008-11-06

Pharmaceutical compositions including low dosages of desmopressin

#3013
20080274098
2008-11-06

Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

#3014
20080267969
2008-10-30

Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway

#3015
20080262199
2008-10-23

Protein kinase C peptides for use in withdrawal

#3016
20080261893
2008-10-23

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#3017
20080255053
2008-10-16

METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS

#3018
20080255037
2008-10-16

Endoparasiticidal Compositions

#3019
20080254051
2008-10-16

Use of native peptides and their optimized derivatives for vaccination

#3020
20080242638
2008-10-02

Induction of differential stress resistance and uses thereof

#3021
20080242618
2008-10-02

Stratification

#3022
20080241275
2008-10-02

Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds

#3023
20080241274
2008-10-02

Indibulin therapy

#3024
20080241194
2008-10-02

COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUE AND CELLS FROM IMMUNE SYSTEM-MEDIATED DAMAGE

#3025
20080234188
2008-09-25

Antimicrobial Peptides

#3026
20080233108
2008-09-25

METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS USING ANTAGONISTS

#3027
20080227725
2008-09-18

Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes

#3028
20080227723
2008-09-18

Peptides for preventing or treating liver damage

#3029
20080227722
2008-09-18

Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization

#3030
20080227721
2008-09-18

Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

#3031
20080227689
2008-09-18

Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1

#3032
20080221039
2008-09-11

Kinin Antagonists For Treating Bladder Dysfunction

#3033
20080220093
2008-09-11

METHODS FOR PRODUCTION OF THE OXIDIZED GLUTATHIONE COMPOSITE WITH CIS-DIAMMINEDICHLOROPLATINUM AND PHARMACEUTICAL COMPOSITIONS BASED THEREOF REGULATING METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOTIC MECHANISMS FOR NORMAL AND TRANSFORMED CELLS

#3034
20080214456
2008-09-04

Lkktet and/or Lkktnt Peptide Compositions and Methods

#3035
20080213176
2008-09-04

Compositions for Targeting Amine Oxidases in Vivo

#3036
20080207526
2008-08-28

Synthetic peptides and methods of use for autoimmune disease therapies

#3037
20080207525
2008-08-28

IAP BIR domain binding compounds

#3038
20080207524
2008-08-28

MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES

#3039
20080207492
2008-08-28

Amphipathic glycopeptides

#3040
20080200400
2008-08-21

Dermatological compositions including oligopeptides for increasing skin sensitivity and neuronal perception

#3041
20080194663
2008-08-14

Sustained release polymer

#3042
20080194490
2008-08-14

AT4 RECEPTOR LIGANDS AS ANGIOGENIC, ANTI-ANGIOGENIC, AND ANTI-TUMOR AGENTS

#3043
20080194489
2008-08-14

Treatment of iatrogenic disease

#3044
20080194467
2008-08-14

CANCER TREATMENT METHODS USING CADHERIN ANTAGONISTS IN COMBINATION WITH ANTICANCER AGENTS

#3045
20080188641
2008-08-07

METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS

#3046
20080187548
2008-08-07

NY-ESO-1 peptides which bind to class II molecules and uses thereof

#3047
20080176806
2008-07-24

Therapeutic uses of tri-, tetra-, penta-, and polypeptides

#3048
20080171853
2008-07-17

Somatostatin antagonists

#3049
20080167388
2008-07-10

Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis

#3050
20080167250
2008-07-10

Method for induction and enhancement of apoptosis in tumor cells

#3051
20080167249
2008-07-10

Protective factors against inflammation, burns and noxious stimuli

#3052
20080166397
2008-07-10

Pain-sensitive therapeutic wound dressing

#3053
20080153757
2008-06-26

Skin rejuvenation cream

#3054
20080153755
2008-06-26

Treatment of tumors

#3055
20080153752
2008-06-26

INHIBITORS OF GLYCOSAMINOGLYCANS

#3056
20080139479
2008-06-12

Bladder tumor-targeting peptide and use thereof

#3057
20080139458
2008-06-12

Methods of Treatment For Injured or Diseased Joints

#3058
20080138426
2008-06-12

Remedies for sex hormone dependent disease

#3059
20080131430
2008-06-05

Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

#3060
20080114025
2008-05-15

Cardiovascular compositions and methods using combinations of anti-platelet agents

#3061
20080113898
2008-05-15

METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS USING PEPTIDES

#3062
20080103100
2008-05-01

Materials and methods for the treatment of celiac disease

#3063
20080096948
2008-04-24

Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation

#3064
20080095849
2008-04-24

Peptide sustained release compositions and uses thereof

#3065
20080095819
2008-04-24

Composition and methods for promoting wound healing and tissue regeneration

#3066
20080095754
2008-04-24

OPHTHALMIC COMPOSITIONS COMPRISING DIGLYCINE

#3067
20080095732
2008-04-24

Personal care compositions

#3068
20080090760
2008-04-17

Compositions and Methods for Inhibiting Cellular Proliferation

#3069
20080076719
2008-03-27

IMMUNOREGULATORY COMPOSITIONS

#3070
20080075706
2008-03-27

Pharmaceutical formulation

#3071
20080069812
2008-03-20

IAP BIR domain binding compounds

#3072
20080064640
2008-03-13

MIXTURE FOR TRANSDERMAL DELIVERY OF LOW AND HIGH MOLECULAR WEIGHT COMPOUNDS

#3073
20080064628
2008-03-13

Fibrinogen Targetting Microparticles For Promoting Haemostasis

#3074
20080058264
2008-03-06

Amino-acid containing composition for inhibiting accumulation of fat

#3075
20080051690
2008-02-28

Combination therapy for the treatment of Alzheimer's disease

#3076
20080051434
2008-02-28

Hemiasterlin derivatives and uses thereof in the treatment of cancer

#3077
20080051346
2008-02-28

Compounds and methods for modulating cell-adhesion mediated drug resistance

#3078
20080045461
2008-02-21

N-terminally modified GLP-1 receptor modulators

#3079
20080044494
2008-02-21

Skin care compositions containing silicone elastomers

#3080
20080039395
2008-02-14

METHODS FOR TREATING SEPTIC SHOCK

#3081
20080038310
2008-02-14

Medical device coated with a coating containing elastin pentapeptide VGVPG

#3082
20080038199
2008-02-14

Methods related to the treatment of neurodegenerative and inflammatory conditions

#3083
20080032918
2008-02-07

Mast cell-derived renin

#3084
20080031956
2008-02-07

Bioimplant formulation comprising lecithin and stearin

#3085
20080027008
2008-01-31

Antitumorigenic Drug Combination

#3086
20080027007
2008-01-31

Control of radiation injury

#3087
20080025978
2008-01-31

Method for inhibiting apoptosis through the p75 neurotrophin receptor

#3088
20080020974
2008-01-24

SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME X

#3089
20080020970
2008-01-24

Somatostatin antagonists

#3090
20080015150
2008-01-17

Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity

#3091
20080014218
2008-01-17

USE OF TIGHT JUNCTION AGONISTS TO FACILITATE PULMONARY DELIVERY OF THERAPEUTIC AGENTS

#3092
20080014143
2008-01-17

Methods and compositions for targeting gC1qR/p32

#3093
20080008760
2008-01-10

Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry

#3094
20080008694
2008-01-10

METHODS TO PREVENT AND TREAT DISEASES

#3095
20080008650
2008-01-10

Endometriosis cell targeting peptide and uses thereof

#3096
20080004224
2008-01-03

DERMATOLOGICAL USES OF TRI-, TETRA-, PENTA-, AND POLYPEPTIDES

#3097
20080004223
2008-01-03

DERMATOLOGICAL USES OF THE TRIPEPTIDE MELANOCYTE STIMULATING INHIBITORY FACTOR (MIF)

#3098
20080004222
2008-01-03

Antitumorigenic Drug Combination

#3099
20080004211
2008-01-03

Inhibitors of Amyloid Fibril Formation and Uses Thereof

#3100
20070293416
2007-12-20

CEACAM based antibacterial agents

#3101
20070292506
2007-12-20

Sustained release formulations

#3102
20070286885
2007-12-13

Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating

#3103
20070275885
2007-11-29

Microcystins as agents for treatment of cancer

#3104
20070274951
2007-11-29

Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto

#3105
20070274931
2007-11-29

Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner

#3106
20070265207
2007-11-15

Pharmaceutical compositions including low dosages of desmopressin

#3107
20070265191
2007-11-15

Pharmaceutical compositions and methods for peptide treatment

#3108
20070264195
2007-11-15

Modulation of activity of neurotrophins

#3109
20070259818
2007-11-08

Methods and compositions for treating conditions

#3110
20070259817
2007-11-08

CLK-peptide and SLK-peptide

#3111
20070259813
2007-11-08

Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent

#3112
20070259811
2007-11-08

Method of modulating the proliferation of medullary thyroid carcinoma cells

#3113
20070259378
2007-11-08

Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1

#3114
20070254811
2007-11-01

Methods for modulating activities in plants

#3115
20070253899
2007-11-01

Dual function polymer micelles

#3116
20070243132
2007-10-18

Transdermal delivery of pharmaceutical agents

#3117
20070238670
2007-10-11

Methods for promoting, inhibiting and detecting toxin entry into cells

#3118
20070238654
2007-10-11

Methods of treating age-related macular degeneration by compstatin and analogs thereof

#3119
20070237735
2007-10-11

Anti-aging composition, kit and method of use

#3120
20070231316
2007-10-04

Treatment of Cognitive Dysfunction in Lupus

#3121
20070225315
2007-09-27

Methods of treating muscular wasting diseases using NF-κB activation inhibitors

#3122
20070225226
2007-09-27

C-REACTIVE PROTEIN APHERESIS

#3123
20070225221
2007-09-27

Methods of treatment using specific binding agents of human angiopoietin-2

#3124
20070219139
2007-09-20

Immune-modulating peptide

#3125
20070219136
2007-09-20

Methods and compositions for treating inflammatory disorders

#3126
20070218121
2007-09-20

Compounds that inhibit caspase activity for treating glaucoma

#3127
20070203066
2007-08-30

Compositions and methods for inhibiting cellular proliferation

#3128
20070203062
2007-08-30

Compositions and methods for promoting hemostasis and other physiological activities

#3129
20070203055
2007-08-30

Compounds and compositions for prevention of overdose of oxycodone

#3130
20070197436
2007-08-23

Peptidyl diacylglycerides

#3131
20070196501
2007-08-23

Formulations for a tight junction effector

#3132
20070196272
2007-08-23

ORAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS

#3133
20070196269
2007-08-23

Pharmaceutical composition

#3134
20070191283
2007-08-16

Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues

#3135
20070191281
2007-08-16

Compound containing a labile disulfide bond

#3136
20070185348
2007-08-09

P-selectin targeting ligand and compositions thereof

#3137
20070185203
2007-08-09

Compositions and methods for treating diseases

#3138
20070185035
2007-08-09

ENHANCED MUCOSAL ADMINISTRATION OF NEUROPROTECTIVE PEPTIDES

#3139
20070185029
2007-08-09

Method of treating condition in animal

#3140
20070179099
2007-08-02

Methods of cholesterol reduction using isoflavones

#3141
20070179085
2007-08-02

MODULATION OF RHAMM-CAVEOLIN/LIPID RAFT INTERACTIONS TO AFFECT DEVELOPMENT, RESPONSES TO TISSUE INJURY, ANGIOGENESIS, TUMORIGENESIS, METASTASIS AND GROWTH FACTOR/CYTOKINE RESPONSES

#3142
20070167359
2007-07-19

Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles

#3143
20070167356
2007-07-19

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

#3144
20070167354
2007-07-19

Hydrogels for modulating cell migration and matrix deposition

#3145
20070161789
2007-07-12

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#3146
20070161572
2007-07-12

Drug therapy for Celiac Sprue

#3147
20070161570
2007-07-12

Methionine aminopeptidase-2 inhibitors and methods of use thereof

#3148
20070161557
2007-07-12

Casein derived peptides and uses thereof in therapy

#3149
20070161544
2007-07-12

SELECTIVE TARGETING AGENTS FOR MITCOCHONDRIA

#3150
20070161078
2007-07-12

Methods and compositions for diagnosis and treatment of influenza

#3151
20070160573
2007-07-12

Peptide conjugated anti-cancer prodrugs

#3152
20070160536
2007-07-12

Tumor activated prodrugs

#3153
20070154882
2007-07-05

Beta-polypeptides that inhibit cytomegalovirus infection

#3154
20070149458
2007-06-28

Uses of myostatin antagonists

#3155
20070149457
2007-06-28

Stable solid forms of enterostatin

#3156
20070149444
2007-06-28

Peptides that home to tumor lymphatic vasculature and methods of using same

#3157
20070149443
2007-06-28

Methods of treating obesity using enterostatin

#3158
20070149442
2007-06-28

Non-hygroscopic compositions of enterostatin

#3159
20070142314
2007-06-21

Decoy-containing pharmaceutical compositions and method of using the same

#3160
20070142272
2007-06-21

Neuroprotective activity of activated protein c independent of its anticoagulant activity

#3161
20070142267
2007-06-21

Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells

#3162
20070129306
2007-06-07

Methods for reducing CD36 expression

#3163
20070129303
2007-06-07

Methods for production of growth-promoting proteins and peptides for kidney epithelial cells

#3164
20070123466
2007-05-31

Method of treating recurrent miscarriages

#3165
20070123450
2007-05-31

Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells

#3166
20070122485
2007-05-31

Organic compounds

#3167
20070116694
2007-05-24

Inhibitor of interaction of granzyme b with golgin-160

#3168
20070111931
2007-05-17

Compositions and methods for promoting wound healing and tissue repair

#3169
20070105781
2007-05-10

Inhibitors of serine proteases

#3170
20070099840
2007-05-03

Hydrogel compositions

#3171
20070098776
2007-05-03

HLA class I A2 tumor associated antigen peptides and vaccine compositions

#3172
20070098707
2007-05-03

Methods and Compositions for Inhibiting C-MET Dimerization and Activation

#3173
20070093422
2007-04-26

Drug comprising synthetic peptide analogs for the treatment of cancer

#3174
20070093419
2007-04-26

Methods of treatment using specific binding agents of human angiopoietin-2

#3175
20070093418
2007-04-26

Methods of treatment using specific binding agents of human angiopoietin-2

#3176
20070092575
2007-04-26

Compositions for administering RNAIII-inhibiting peptides

#3177
20070092508
2007-04-26

Detoxification depot for Alzheimer's disease

#3178
20070087971
2007-04-19

Peptides, derivatives and analogs thereof, and methods of using same

#3179
20070082849
2007-04-12

Angiogenic peptides and uses thereof

#3180
20070082841
2007-04-12

Ocular administration of immunosuppressive agents

#3181
20070078090
2007-04-05

Anti-chrondrosarcoma compounds

#3182
20070072801
2007-03-29

Methods of treatment using specific binding agents of human angiopoietin-2

#3183
20070072790
2007-03-29

Antitumor agents

#3184
20070072251
2007-03-29

In vivo imaging using peptide derivatives

#3185
20070071768
2007-03-29

Use of RIP in treating infections

#3186
20070071722
2007-03-29

Composition comprising a nucleotide sequence encoding an ELA2 fusion protein and plasmacytoid dendritic cells

#3187
20070066526
2007-03-22

Method for reducing risk of and extent of injury due to stroke in hypertensive subjects

#3188
20070065399
2007-03-22

Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules

#3189
20070054332
2007-03-08

Syndecan 1 ectodomain inhibits cancer

#3190
20070053838
2007-03-08

Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor

#3191
20070042964
2007-02-22

Compositions and methods for modulating connexin hemichannels

#3192
20070042962
2007-02-22

Peptide dependent upregulation of telomerase expression

#3193
20070042492
2007-02-22

Sequences facilitating penetration of a substance of interest

#3194
20070041902
2007-02-22

Somatostatin analogs with inhibitory activity to growth hormone release

#3195
20070037252
2007-02-15

Compositions and methods for topical application and transdermal delivery of an oligopeptide

#3196
20070037211
2007-02-15

Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of

#3197
20070027070
2007-02-01

Medicinal uses of mu-opioid receptor agonists

#3198
20070021351
2007-01-25

Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor

#3199
20070021347
2007-01-25

Treatment of tumors using short peptides from human chorionic gonadotropin (HCG)

#3200
20070015711
2007-01-18

Methods for reducing oxidative damage

#3201
20070015685
2007-01-18

Bone cement compositions and the like comprising an RNAIII-inhibiting peptide

#3202
20070014742
2007-01-18

INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES

#3203
20070010452
2007-01-11

Methionine aminopeptidase-2 inhibitors and methods of use thereof

#3204
20070010431
2007-01-11

Pharmaceutical formulations and methods of treatment using the same

#3205
20070010428
2007-01-11

Inhibitors of signal transduction and activator of transcription 3

#3206
20070009926
2007-01-11

Biomarkers of resistance to infections in humans and biological applications thereof

#3207
20070009602
2007-01-11

Direct drug delivery system based on thermally responsive biopolymers

#3208
20070009569
2007-01-11

Methods and compositions for the treatment and prevention of and other bacterial infections

#3209
20070009469
2007-01-11

Treatment of skin, and wound repair, with thymosin beta 4

#3210
20070004635
2007-01-04

Method of treating interferon non-responders using HCV protease inhibitor

#3211
20070004634
2007-01-04

Insulin and IGF-1 receptor agonists and antagonists

#3212
20070004633
2007-01-04

Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment

#3213
20060293237
2006-12-28

ψεRACK peptide composition and method for protection against tissue damage due to ischemia

#3214
20060293231
2006-12-28

Method for enhancing bone formation

#3215
20060287233
2006-12-21

Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells

#3216
20060286155
2006-12-21

Pain-sensitive therapeutic wound dressings

#3217
20060281739
2006-12-14

Compositions and methods for treatment of eye disorders

#3218
20060281689
2006-12-14

Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period

#3219
20060281688
2006-12-14

Administration of HCV protease inhibitors in combination with food to improve bioavailability

#3220
20060281682
2006-12-14

Methods and compositions for the treatment of gastrointestinal disorders

#3221
20060280812
2006-12-14

Compositions and methods for the treatment of muscular dystrophy

#3222
20060276407
2006-12-07

Methods of treating hepatitis C virus

#3223
20060275351
2006-12-07

TOPICAL OLIGOPEPTIDE DELIVERY SYSTEM

#3224
20060263422
2006-11-23

Pharmaceutical composition containing decoy and use of the same

#3225
20060263360
2006-11-23

Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives

#3226
20060258597
2006-11-16

Antitumorigenic drug combination and dosing schedule

#3227
20060252698
2006-11-09

Compounds for inhibiting cathepsin activity

#3228
20060252691
2006-11-09

Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections

#3229
20060247165
2006-11-02

Methods and compositions for encapsulation of cells

#3230
20060246113
2006-11-02

Bio-synthetic matrix and uses thereof

#3231
20060246104
2006-11-02

Stable rgd peptidomimetic composition

#3232
20060240026
2006-10-26

Preventing and/or remedy hematopoietic tumor

#3233
20060234947
2006-10-19

Peptides directed for diagnosis and treatment of amyloid-associated disease

#3234
20060234945
2006-10-19

Ophthalmic therapeutic composition

#3235
20060234942
2006-10-19

Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements

#3236
20060234938
2006-10-19

Peptides impairing PBX dependent gene regulation

#3237
20060234908
2006-10-19

Methods for improving the structure and function of arterioles

#3238
20060234905
2006-10-19

Method of stimulating growth and resistance to diseases of aquatic organisms

#3239
20060223760
2006-10-05

Compositions and methods for treatment of cancer

#3240
20060223741
2006-10-05

Method of treatment or prophylaxis

#3241
20060217316
2006-09-28

Method for the treatment of prostate cancer

#3242
20060217307
2006-09-28

Methods for regulating inflammatory mediators and peptides useful therein

#3243
20060211624
2006-09-21

Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies

#3244
20060204980
2006-09-14

Colorectal cancer therapies

#3245
20060199771
2006-09-07

Stereoselective antifibrillogenic peptides and peptidomimetics thereof

#3246
20060193901
2006-08-31

Mixture for transdermal delivery of low and high molecular weight compounds

#3247
20060189541
2006-08-24

Methods of treating dry eye disorders

#3248
20060189540
2006-08-24

Peptides for diagnostic and therapeutic methods for celiac sprue

#3249
20060189523
2006-08-24

Use of effectors of glutaminyl and glutamate cyclases

#3250
20060188531
2006-08-24

Mixture for transdermal delivery of low and high molecular weight compounds

#3251
20060178313
2006-08-10

Use of a polypeptide for treatment of pruritus in animals

#3252
20060172949
2006-08-03

Compositions for preventing and treating digestive organs diseases

#3253
20060172943
2006-08-03

Restoring vascular function

#3254
20060172938
2006-08-03

Peptide inhibitors against seprase

#3255
20060171944
2006-08-03

N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response

#3256
20060167402
2006-07-27

Method and composition for inhibiting cardiovascular cell proliferation

#3257
20060166867
2006-07-27

Novel conjugates of polysaccharides and uses thereof

#3258
20060160744
2006-07-20

Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder

#3259
20060160743
2006-07-20

Peptides that selectively home to heart vasculature and related conjugates and methods

#3260
20060159719
2006-07-20

Method and composition for inhibiting cardiovascular cell proliferation

#3261
20060159663
2006-07-20

Growth factor encapsulation system for enhancing bone formation

#3262
20060154863
2006-07-13

Methods and compositions for modulating conditions in both mammals and plants

#3263
20060153867
2006-07-13

Pharmaceutical formulation

#3264
20060153861
2006-07-13

BCR-ABL imatinib resistance-associated peptides and methods of use thereof

#3265
20060149037
2006-07-06

Cupredoxin derived transport agents and methods of use thereof

#3266
20060148714
2006-07-06

Therapeutic peptide-based constructs

#3267
20060148702
2006-07-06

Methods of increasing cerebral blood flow

#3268
20060148683
2006-07-06

Detection and treatment of intravascular lesions

#3269
20060142203
2006-06-29

Compositions and methods comprising protein activated receptor antagonists

#3270
20060142190
2006-06-29

Synthetic peptide, inhibitor to DNA viruses

#3271
20060135435
2006-06-22

Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer

#3272
20060135403
2006-06-22

Therapeutic formulations for the treatment of beta-amyloid related diseases

#3273
20060134050
2006-06-22

Bio-synthetic matrix and uses thereof

#3274
20060128631
2006-06-15

Peptides and derivatives thereof showing cell attachment, spreading and detachment activity

#3275
20060128630
2006-06-15

AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

#3276
20060128628
2006-06-15

Human tissue antigen-binding peptides and their amino acid sequences

#3277
20060122122
2006-06-08

Antimicrobial peptides and use thereof

#3278
20060122120
2006-06-08

Method of reducing the effects of Abeta and compositions therefore

#3279
20060122103
2006-06-08

Dalfopristine/quinupristine combinations with cefpirome

#3280
20060121120
2006-06-08

Sustained release ionic conjugate

#3281
20060111301
2006-05-25

Methods for preventing and treating Alzheimer's disease

#3282
20060106198
2006-05-18

Antimicrobials against pathogenic bacteria and method for screening them

#3283
20060104898
2006-05-18

Ligands to radiation-induced molecules

#3284
20060100155
2006-05-11

Method for the therapeutic management of endometriosis

#3285
20060094672
2006-05-04

Compositions and methods of use of targeting peptides against placenta and adipose tissues

#3286
20060089310
2006-04-27

Treatment of infections and other disorders

#3287
20060088497
2006-04-27

Topical skin care composition

#3288
20060084611
2006-04-20

Apoptotic compounds

#3289
20060084606
2006-04-20

Methods for reducing oxidative damage

#3290
20060074027
2006-04-06

Sustained-release preparations

#3291
20060069035
2006-03-30

Peptide for regulation of urokinase plasminogen activator and method of optimizing therapeutic efficacy

#3292
20060057064
2006-03-16

Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient

#3293
20060052312
2006-03-09

Paclitaxel hybrid derivatives

#3294
20060052309
2006-03-09

Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring

#3295
20060039883
2006-02-23

Biologically active compounds for the modification of bodily odours

#3296
20060035812
2006-02-16

Neuroprotective dietary supplement

#3297
20060035811
2006-02-16

Methods of treating dry eye disease with lantibiotics

#3298
20060034941
2006-02-16

Organ preconditioning, arrest, protection, preservation and recovery

#3299
20060029667
2006-02-09

Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents

#3300
20060029579
2006-02-09

Methods for producing target cell reactive lymphocytes